Skip to main content

Potential Links Between Tendon Pathology and Platelet Rich Plasma Biology

  • Chapter
  • First Online:
Platelet Rich Plasma in Musculoskeletal Practice

Abstract

Tendons are prone to chronic lesions, especially in the presence of risk factors such as overuse, trauma and metabolic disorders. Current therapies cannot meet the clinical demand for tendon conditions, and biological interventions such as Platelet Rich Plasma (PRP) can provide a critical opportunity to benefit patients with tendinopathy. Assuming that tendon pathology is consequence of a failed healing response to tissue micro-damage, the signalling cytokines in PRP can modify tissue microenvironment, and enhance healing mechanisms. PRP hypothesis is based on biological hallmarks of tendinopathy, including inflammation, stem cell exhaustion and aberrant differentiation, tenocyte dysfunction with disorganization of extracellular matrix (ECM), altered intercellular communication and subsequent transition from health to disease. PRP can act against by modulating inflammation and angiogenesis, stimulating proliferation of tenocytes and tendon progenitor cells, and tissue anabolism. Progress in translational PRP research would help to establish a comprehensive description of the relationship between PRP essential components, main pathological components of tendinopathy and healing mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abate M, Schiavone C, Salini V, Andia I. Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford). 2013;52(4):599–608.

    Article  CAS  Google Scholar 

  2. Abate M, Silbernagel KG, Siljeholm C, Di Iorio A, De Amicis D, Salini V, Werner S, Paganelli R. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther. 2009;11(3):235.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Andia I, Maffulli N. Meeting current musculoskeletal health demand through deeper insights into tissue homeostasis and regeneration. Expert Opin Biol Ther. 2015;15(6):767–71.

    Article  CAS  PubMed  Google Scholar 

  4. Andia I, Rubio-Azpeitia E, Maffulli N. Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res. 2015;473(5):1624–34.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Andia I, Rubio-Azpeitia E, Maffulli N. Hyperuricemic PRP in tendon cells. Biomed Res Int. 2014;2014:926481.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Andia I, Latorre PM, Gomez MC, Burgos-Alonso N, Abate M, Maffulli N. Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systematic review and meta-analysis of controlled studies. Br Med Bull. 2014;110(1):99–115.

    Article  CAS  PubMed  Google Scholar 

  7. Andia I, Maffulli N. Muscle and tendon injuries: the role of biological interventions to promote and assist healing and recovery. Arthroscopy. 2015;31(5):999–1015.

    Article  PubMed  Google Scholar 

  8. Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721–30.

    Article  CAS  PubMed  Google Scholar 

  9. Andia I, Rubio-Azpeitia E. Angiogenic and innate immune responses triggered by PRP in tendon cells are not modified by hyperuricemia. Muscles Ligaments Tendons J. 2014;4(3):292–7.

    PubMed  PubMed Central  Google Scholar 

  10. Andia I, Sanchez M, Maffulli N. Basic science: molecular and biological aspects of platelet rich plasma therapies. Oper Tech Orthop. 2012;22:3–9.

    Article  Google Scholar 

  11. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther. 2010;10(10):1415–26.

    Article  PubMed  Google Scholar 

  12. Battery L, Maffulli N. Inflammation in overuse tendon injuries. Sports Med Arthrosc. 2011;19(3):213–7.

    Article  PubMed  Google Scholar 

  13. Behzad H, Sharma A, Mousavizadeh R, Lu A, Scott A. Mast cells exert pro-inflammatory effects of relevance to the pathophysiology of tendinopathy. Arthritis Res Ther. 2013;15(6):R184.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti- inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kB inhibition via HGF. J Cell Physiol. 2010;225:757–66.

    Article  CAS  PubMed  Google Scholar 

  15. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007;13(10):1219–27.

    Article  CAS  PubMed  Google Scholar 

  16. Chabot V, Dromard C, Rico A, Langonné A, Gaillard J, Guilloton F, Casteilla L, Sensebé L. Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem/stromal cell migration. Stem Cell Res Ther. 2015;6:188.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chaterjee M, Huang Z, Zhang W, et al. Distinct platelet packaging, release and surface expression of proangiogenic and antiangiogenic factors upon different platelet stimuli. Blood. 2011;117:3907–11.

    Article  Google Scholar 

  18. Coudriet GM, He J, Trucco M, et al. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One. 2010;11, e15384.

    Article  Google Scholar 

  19. Czekay R-P, Wilkins-Port CE, Higgins SP, et al. PAI-1: an integrator of cell signalling and migration. Int J Cell Biol. 2011;2011:562481.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dakin SG, Martinez FO, Yapp C, Wells G, Oppermann U, Dean BJ, Smith RD, Wheway K, Watkins B, Roche L, Carr AJ. Inflammation activation and resolution in human tendon disease. Sci Transl Med. 2015;7(311):311ra173.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Del Buono A, Oliva F, Osti L, Maffulli N. Metalloproteases and tendinopathy. Muscles Ligaments Tendons J. 2013;3(1):51–7.

    PubMed  PubMed Central  Google Scholar 

  22. Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014;4(1):3–9.

    PubMed  PubMed Central  Google Scholar 

  23. Flad HD, Brandt E. Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol Life Sci. 2010;67:2363–86.

    Article  CAS  PubMed  Google Scholar 

  24. Gleissner CA, Shaked I, Little KM, et al. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol. 2010;184:4810–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Karousou E, Ronga M, Vigetti D, Barcolli D, Passi A, Maffulli N. Molecular interactions in extracellular matrix of tendon. Front Biosci (Elite Ed). 2010;2:1–12.

    Google Scholar 

  26. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204(3):322–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kozlova N, Jensen JK, Chi TF, Samoylenko A, Kietzmann T. PAI-1 modulates cell migration in a LRP1-dependent manner via β-catenin and ERK1/2. Thromb Haemost. 2015;113(5):988–98.

    Article  PubMed  Google Scholar 

  28. Krysko DV, D’Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis. 2006;11:1709–26.

    Article  PubMed  Google Scholar 

  29. Maffulli N, Longo UG, Berton A, Loppini M, Denaro V. Biological factors in the pathogenesis of rotator cuff tears. Sports Med Arthrosc. 2011;19(3):194–201.

    Article  PubMed  Google Scholar 

  30. Martin JI, Merino J, Atilano L, Areizaga LM, Gomez-Fernandez MC, Burgos-Alonso N, Andia I. Platelet-rich plasma (PRP) in chronic epicondylitis: study protocol for a randomized controlled trial. Trials. 2013;14:410.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–46.

    Article  CAS  PubMed  Google Scholar 

  32. Maynard DM, Heijnen HF, Gahl WA, et al. The a-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost. 2010;8:1786–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Millar NL, Murrell GA. Heat shock proteins in tendinopathy: novel molecular regulators. Mediators Inflamm. 2012;2012:436203.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest. 1971;50(2):370–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nourissat G, Berenbaum F, Duprez D. Tendon injury: from biology to tendon repair. Nat Rev Rheumatol. 2015;11(4):223–33.

    Google Scholar 

  36. Peterson JE, Zurakowski D, Italiano JE, et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol. 2010;85:487–93.

    Article  CAS  PubMed  Google Scholar 

  37. Poon IK, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ. 2010;17:381–97.

    Article  CAS  PubMed  Google Scholar 

  38. Popov C, Burggraf M, Kreja L, Ignatius A, Schieker M, Docheva D. Mechanical stimulation of human tendon stem/progenitor cells results in upregulation of matrix proteins, integrins and MMPs, and activation of p38 and ERK1/2 kinases. BMC Mol Biol. 2015;16:6.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Rees JD, Stride M, Scott A. Tendons – time to revisit inflammation. Br J Sports Med. 2014;48(21):1553–7.

    Article  PubMed  Google Scholar 

  40. Reiss RF, Katz AJ. Optimizing recovery of platelets in platelet rich plasma by the simplex strategy. Transfusion. 1976;16(4):370–4.

    Article  CAS  Google Scholar 

  41. Sánchez M, Azofra J, Anitua E, Andía I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc. 2003;35(10):1648–52.

    Article  PubMed  Google Scholar 

  42. Sánchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39(5):345–54.

    Article  PubMed  Google Scholar 

  43. Spiesz EM, Thorpe CT, Chaudhry S, Riley GP, Birch HL, Clegg PD, Screen HR. Tendon extracellular matrix damage, degradation and inflammation in response to in vitro overload exercise. J Orthop Res. 2015;33(6):889–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Tempfer H, Kaser-Eichberger A, Korntner S, Lehner C, Kunkel N, Traweger A, Trost A, Strohmaier C, Bogner B, Runge C, Bruckner D, Krefft K, Heindl LM, Reitsamer HA, Schrödl F. Presence of lymphatics in a rat tendon lesion model. Histochem Cell Biol. 2015;143(4):411–9.

    Article  CAS  PubMed  Google Scholar 

  45. Tempfer H, Traweger A. Tendon vasculature in health and disease. Front Physiol. 2015;6:330.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Villeneuve J, Block A, Le Bousse-Kerdilès MC, et al. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. Exp Hematol. 2009;37:849–56.

    Article  CAS  PubMed  Google Scholar 

  47. Warden SJ. Animal models for the study of tendinopathy. Br J Sports Med. 2007;41(4):232–40.

    Article  CAS  PubMed  Google Scholar 

  48. Zaslavsky A, Baek KH, Lynch RC, et al. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood. 2010;115:4605–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabel Andia PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London

About this chapter

Cite this chapter

Andia, I., Rubio-Azpeitia, E., Maffulli, N. (2016). Potential Links Between Tendon Pathology and Platelet Rich Plasma Biology. In: Maffulli, N. (eds) Platelet Rich Plasma in Musculoskeletal Practice. Springer, London. https://doi.org/10.1007/978-1-4471-7271-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-7271-0_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-7270-3

  • Online ISBN: 978-1-4471-7271-0

  • eBook Packages: Medicine

Publish with us

Policies and ethics